Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell Lymphomas (clinicaltrials.gov) - Oct 21, 2026 - P2 | N=40 | Recruiting | Sponsor: National Research Center for Hematology, Russia
New P2 trial • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • CD19
|